Sign in Subscribe
Cytological research

Cervical Cancer Screening Strategies Show Promise

Strategic Insights

— 2 min read

Researchers in the United States have conducted a study on the accuracy and cost-effectiveness of cervical cancer screening strategies based on high-risk human papillomavirus (HPV) DNA testing of self-collected vaginal samples. The study, which involved a subset of 1,665 women aged 18-50, compared five different screening strategies, including high-risk HPV DNA testing of self-collected vaginal samples, clinician-collected cervical samples, and a combination of both. The results showed that self-collected vaginal samples were more sensitive but less specific than clinician-collected samples. However, a strategy of high-risk HPV DNA testing followed by cytology triage of HPV-positive women was found to be comparably sensitive and specific to cytology-based screening.

Key Takeaways:

  • The study involved 1,665 women aged 18-50 who participated in a cervical cancer screening study.
  • The researchers compared five different screening strategies, including high-risk HPV DNA testing of self-collected vaginal samples.
  • Self-collected vaginal samples were found to be 68% sensitive (95% CI=58%-78%) but 89% specific (95% CI=86%-91%).
  • A strategy of high-risk HPV DNA testing followed by cytology triage of HPV-positive women was found to be 75% sensitive (95% CI=64%-86%) and 88% specific (95% CI=85%-92%).
  • In-home self-collection for high-risk HPV DNA detection followed by in-clinic cytology triage had a slightly lower lifetime cost and a slightly higher quality-adjusted life year (QALY) expectancy than did cytology-based screening.
  • The study concluded that triennial screening by high-risk HPV DNA testing of in-home, self-collected vaginal samples followed by in-clinic cytology triage was cost-effective.
  • The researchers identified a geriatric patient with advanced-stage cervical cancer who was reclassified to an actual low-risk category based on genetic testing.

Statistics:

  • The study involved 1,665 women aged 18-50.
  • The sensitivity of self-collected vaginal samples was 68% (95% CI=58%-78%).
  • The specificity of self-collected vaginal samples was 89% (95% CI=86%-91%).
  • The sensitivity of high-risk HPV DNA testing followed by cytology triage was 75% (95% CI=64%-86%).
  • The specificity of high-risk HPV DNA testing followed by cytology triage was 88% (95% CI=85%-92%).
  • The incremental cost-effectiveness ratio for triennial screening by high-risk HPV DNA testing of in-home, self-collected vaginal samples followed by in-clinic cytology triage was $9,871/QALY.
  • The incremental cost-effectiveness ratio for cytology-based screening was $12,878/QALY.

Sources:

  • Balasubramanian, A., et al. (2010). Accuracy and cost-effectiveness of cervical cancer screening by high-risk human papillomavirus DNA testing of self-collected vaginal samples. Journal of Lower Genital Tract Disease, 14(3), 185-95.
  • Human Papillomavirus (see also).
  • Blackwell Publishing Inc. (Publisher contact information for the Journal of Lower Genital Tract Disease).
  • OBGYN & Reproduction Week editors (2010). Cervical Cancer Screening Strategies Show Promise. OBGYN & Reproduction Week via NewsRx.com.

Read more